Body Rick
Hope Hospital, Salford, UK.
Emerg Med J. 2009 Jul;26(7):519-22. doi: 10.1136/emj.2009.076182.
A short-cut review was carried out to establish whether the measurement of plasma heart fatty acid binding protein at the time of presentation is of any help in the accurate early diagnosis of acute myocardial infarction (AMI). Six papers presented evidence addressing the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these papers are shown in table 1. The clinical bottom line is that although heart fatty acid binding protein is a promising biomarker it cannot be used alone to rule out the diagnosis of AMI.
进行了一项简短综述,以确定就诊时血浆心脏脂肪酸结合蛋白的检测对急性心肌梗死(AMI)的准确早期诊断是否有任何帮助。六篇论文提供了针对该临床问题的证据。这些论文的作者、发表日期和国家、研究的患者群体、研究类型、相关结局、结果及研究不足见表1。临床要点是,尽管心脏脂肪酸结合蛋白是一种有前景的生物标志物,但不能单独用于排除AMI的诊断。